← Back to Clinical Trials
Recruiting NCT06975800

NCT06975800 Effects of Social Feedback on Intracranial EEG

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06975800
Status Recruiting
Phase
Sponsor Trustees of Dartmouth College
Condition Social Influence
Study Type INTERVENTIONAL
Enrollment 24 participants
Start Date 2023-04-06
Primary Completion 2027-02-28

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Low social feedbackHigh social feedback

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 24 participants in total. It began in 2023-04-06 with a primary completion date of 2027-02-28.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to assess the impact of social influence on direct neural recordings in human patients undergoing surgical treatment of epilepsy. 24 patients recruited from the Epilepsy Center at Dartmouth Health Medical Center (DHMC) will undergo electrode implantation throughout the brain to localize epileptogenic zones. Patients will be asked to rate their provider's warmth, competence, and other, similar traits associated with care-competency. They will then complete the picture-induced fear and math portions of the multimodal negative affect task (MNAT) during which iEEG is recorded.

Eligibility Criteria

Inclusion Criteria: * Patients must be between 18-65 years of age. * Patients must have a diagnosis of refractory epilepsy undergoing intracranial EEG recording for clinical purposes. * Patients with a legal guardian will be considered for participation if they are interested and, in the judgment of the research team, they are capable of performing the cognitive tasks required of the study. In those instances, the patient and their legal guardian will both participate in the informed consent process, with the legal guardian signing the consent form. Exclusion Criteria: * Patient has additional neurological condition (such as stroke or dementia) or a psychiatric condition (such as active psychosis or suicidal ideation) and are deemed inappropriate for the study. * Patients are not able to provide informed consent for any reason (e.g. encephalopathic, experiencing a seizure).

Contact & Investigator

Central Contact

Tor D Wager, PhD

✉ Tor.D.Wager@Dartmouth.edu

📞 603-646-2196

Frequently Asked Questions

Who can join the NCT06975800 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Social Influence. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06975800 currently recruiting?

Yes, NCT06975800 is actively recruiting participants. Contact the research team at Tor.D.Wager@Dartmouth.edu for enrollment information.

Where is the NCT06975800 trial being conducted?

This trial is being conducted at Lebanon, United States.

Who is sponsoring the NCT06975800 clinical trial?

NCT06975800 is sponsored by Trustees of Dartmouth College. The trial plans to enroll 24 participants.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology